Kyverna Therapeutics Inc. (KYTX)
NASDAQ: KYTX
· Real-Time Price · USD
3.53
-0.01 (-0.28%)
At close: Aug 15, 2025, 3:59 PM
3.58
1.42%
After-hours: Aug 15, 2025, 06:09 PM EDT
Kyverna Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -158.7M | -145.42M | -127.48M | -110.66M | -91.63M | -75.92M | -60.37M | -48.2M | -32.73M | -19.64M | -8.5M |
Depreciation & Amortization | 2.14M | 2.15M | 2.13M | 2.03M | 1.91M | 1.79M | 1.71M | 1.62M | 1.18M | 768K | 374K |
Stock-Based Compensation | 9.47M | 8.24M | 8.36M | 7.76M | 4.87M | 4.03M | 2.22M | 1.77M | 1.25M | 805K | 337K |
Other Working Capital | 6.37M | 6.06M | 7.12M | -181K | 2.49M | -4.01M | -697K | 991K | -1.87M | -1.87M | -282K |
Other Non-Cash Items | -591K | -1.06M | 227K | 2.23M | -610K | 1.42M | 1.28M | 1.25M | 1.24M | 803K | 419K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 6.26M | 2.44M | 2.79M | 3.77M | 6.95M | 3.07M | 3.42M | 1.1M | -2.27M | -2.79M | -1.31M |
Operating Cash Flow | -141.41M | -133.64M | -114.25M | -95.75M | -79.39M | -66.48M | -52.41M | -42.66M | -31.53M | -20.27M | -8.82M |
Capital Expenditures | -638K | -1.66M | -2.21M | -2.01M | -2.16M | -1.14M | -621K | -299K | -43K | -40K | -12K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -440.62M | -425.78M | -490M | -363.74M | -280.08M | -200.18M | -54.85M | -55.3M | -1.44M | -1.44M | -1.44M |
Sales Maturities Of Investments | 496.72M | 387.46M | 325.87M | 201.87M | 69M | 56M | 46.68M | 30.28M | 30.28M | 30.28M | 16.6M |
Other Investing Acitivies | 9.18M | 7.54M | -116.91M | -84.89M | -90.32M | -90.32M | 45.7M | 28.84M | 28.84M | 28.84M | 15.16M |
Investing Cash Flow | 64.64M | -32.45M | -160.9M | -158.44M | -213.24M | -145.32M | -8.79M | -25.32M | 28.8M | 28.8M | 15.15M |
Debt Repayment | -1.09M | -1.07M | -956K | -928K | -891K | -844K | -781K | -707K | -502K | -313K | -145K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 340.82M | 340.87M | 337.98M | -4.44M | -4.29M | 21.14M | 24.06M | 25.32M | 25.16M | 67K | 43K |
Financial Cash Flow | -1.43M | -1.35M | 337.11M | 335.89M | 370.84M | 396.31M | 58.12M | 59.45M | 24.66M | -246K | -102K |
Net Cash Flow | -78.2M | -167.44M | 61.96M | 81.7M | 78.2M | 184.51M | -3.08M | -8.53M | 21.93M | 8.28M | 6.23M |
Free Cash Flow | -142.05M | -135.3M | -116.45M | -97.76M | -81.56M | -67.61M | -53.03M | -42.96M | -31.57M | -20.32M | -8.83M |